Diagnose

What Diagnose does

Diagnose, S.A. de C.V. is a privately held Mexican clinical laboratory founded in 2004 and headquartered in Naucalpan de Juárez, Estado de México. The company operates four fixed branches across Estado de México (Satélite and Tlalnepantla), Mexico City (Roma Sur), and Guadalajara (Jalisco), supplemented by mobile clinical laboratory units that travel to enterprise and educational facilities for on-site testing. Originally focused on enterprise occupational health, Diagnose opened its laboratory services to the general public in January 2022, adding a direct-to-consumer channel alongside its corporate book of business.

The company's core offering is clinical laboratory diagnostics spanning conventional clinical chemistry, hematology, urinalysis, RT-PCR molecular diagnostics (including influenza A/B detection), rapid antigen testing for COVID-19 and influenza via Roche equipment, and specialized panels such as HbA1c, lipid profiles, and metabolic syndrome assessments. Enterprise services include workplace drug and alcohol screening with documented chain-of-custody protocols, pre-employment and periodic medical examinations, polygraph testing, control de confianza (trust evaluations), NOM-035 psychosocial risk factor evaluations, and on-site corporate health brigades. All operations are conducted under an EMA (Entidad Mexicana de Acreditación) quality assurance system compliant with NOM-007-SSA2-1993, with a Responsable Sanitario holding Cédula Profesional 6032440 from IPN.

Diagnose generates revenue through per-test fees for individual consumers and contracted enterprise service agreements covering bundled occupational health packages, with payment collected in advance of service delivery. The company maintains a digital-first go-to-market built around an educational blog ("Diagnoticias"), organic presence on Facebook and Instagram, SEO-driven content, and direct WhatsApp/phone booking, while enterprise sales rely on direct outreach, referrals, and a dedicated business contact channel. Ownership remains with private shareholders under Mexican corporate law, with no disclosed institutional investors, parent entity, or M&A activity.

Name

Diagnose

Legal name

DIAGNOSE, S.A. DE C.V.

Website

https://diagnose.com.mx

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Diagnose is a Mexican clinical laboratory founded in 2004 that delivers diagnostic testing and occupational health services to corporate clients and the general public through four fixed branches and mobile laboratory units across Estado de México, Mexico City, and Guadalajara.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Point-of-Care Testing (POCT) & Near-Patient Labs (HLAFAMAI)

akta.pro secondary industries

Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF), Drug & Alcohol Testing Coordination (BPACALAE)

Keywords

• Clinical laboratory services
• Occupational health testing
• Toxicological screening
• Mobile laboratory services
• Diagnostic testing services

Headquarters

HQ city

Naucalpan de Juarez

HQ country

Mexico

HQ region

Latin America

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Laboratory Testing Services: Fees charged for clinical analyses of biological samples (blood, urine, etc.) performed at fixed branches or via mobile units. Payment is collected in advance of service delivery. Services are available to both individual patients and corporate clients.
2. Enterprise Occupational Health Services: Bundled service packages for companies including workplace drug testing, alcohol screening, pre-employment medical exams, polygraph tests, and periodic health evaluations. Revenue generated through per-test fees or contracted service agreements with corporate clients.
3. Mobile Laboratory Services: On-site clinical testing delivered via mobile laboratory units to enterprise facilities and schools, generating revenue per deployment or per test performed.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Diagnose is a Mexican clinical laboratory providing diagnostic testing services to enterprise clients (occupational health, drug screening, polygraph, Control de Confianza, and corporate health brigades) and to the general public (blood work, metabolic panels, infectious disease testing, preventive screenings). The company operates four fixed branches across Central and Western Mexico and a mobile laboratory fleet that delivers on-site testing directly to workplaces and schools.

Product overview

Diagnose is a clinical laboratory company providing diagnostic testing services to both enterprises and the general public. The company operates fixed laboratory facilities in Satélite and Tlalnepantla (State of Mexico), with a mobile clinical laboratory unit that brings services directly to workplaces and educational institutions. The core offering consists of clinical laboratory testing (blood tests, urine analysis, molecular diagnostics), complemented by specialized enterprise services including toxicology/toxicological testing, anti-doping testing for industries and schools, control de confianza (trust/background testing), and polygraph testing. For individual consumers, the company offers general health studies including metabolic panels, lipid profiles, HbA1c diabetes monitoring, rapid antigen tests for COVID-19 and influenza (via Roche equipment), and RT-PCR testing for influenza A/B detection. The mobile laboratory service enables on-site sample collection, making it particularly suited for enterprise wellness programs and corporate health brigades.

Differentiator

Problem solved

Functional benefit

Products and services

• Servicios de Laboratorio Clínico (Clinical Laboratory Testing Services) Core clinical laboratory diagnostic testing services covering blood analysis, urine tests, and biological sample analysis for medical diagnosis, health monitoring, and preventive care, available to both enterprise clients and individual patients at fixed branches and via mobile units.
• Laboratorio Clínico Móvil (Mobile Clinical Laboratory Service)

Quantifiable outcome

• HbA1c reduction can predict decrease in diabetic complications including retinopathy (76%), microalbuminuria (34%), macroalbuminuria (44%), and neuropathy (64%)

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

Emerging players

• BioReference Laboratories: Specialized US clinical laboratory with growing work in toxicology and occupational health. Comparable to Diagnose in toxicology and employer testing, though with a different geographic footprint.

Broad incumbents

• Quest Diagnostics: US national clinical laboratory leader with international reach. Overlaps with Diagnose across routine clinical and toxicology testing, with significantly more advanced digital infrastructure.
• Synlab: Large European clinical laboratory group with international operations. Comparable to Diagnose in offering clinical, toxicology, and workplace diagnostics, though at much larger scale.
• Unilabs: European clinical laboratory leader with growing Latin American presence. Competes with Diagnose in clinical diagnostics and has capability to serve enterprise occupational health clients across borders.
• LabCorp: Global clinical laboratory and diagnostics company. Comparable to Diagnose in clinical chemistry and toxicology, with extensive digital patient engagement and enterprise testing capabilities.

Direct peers

• Salud Digna: Mexico's largest low-cost clinical laboratory chain with hundreds of branches nationwide. Directly competes with Diagnose on routine clinical testing, but operates at much greater scale and brand recognition.
• Olarte y Akle: Established Mexican clinical laboratory serving both individuals and corporate clients. Comparable to Diagnose in offering occupational health and routine diagnostics, with a broader national footprint.
• Lister Laboratorios: Mexican clinical laboratory offering routine diagnostics, specialized testing, and corporate services. Directly comparable to Diagnose in customer segments and service mix, with a stronger presence in northern Mexico.
• Chopo: Major Mexican clinical laboratory chain operated by Grupo Proa. Overlaps with Diagnose on routine diagnostic testing for individuals and enterprise clients, with significant national branch coverage.

Regional players

• Lab Polanco: Mexican clinical laboratory concentrated in the Polanco and CDMX metro area. Comparable to Diagnose on routine diagnostic testing but primarily serves a premium urban patient segment.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/diagnosemexico
• Instagraminstagram.com/diagnosemexico
• LinkedInlinkedin.com/company/diagnosemx

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diagnose